## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v
Towards Antitumor Active trans-Platinum Compounds
✍ Scribed by Sheena M. Aris; Nicholas P. Farrell
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 536 KB
- Volume
- 2009
- Category
- Article
- ISSN
- 1434-1948
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Substitution of NH~3~ by a range of amines in trans‐[PtCl~2~(NH~3~)~2~] produces compounds with cytotoxicity significantly improved over the parent transplatin and in many cases equivalent to that of cisplatin. This microreview summarizes the chemistry and biology of trans‐platinum compounds containing principally planar amines and succinctly reviews the current status of anticancer relevance of the trans‐platinum geometry. The nature of bifunctional DNA adducts (intrastrand, interstrand) is remarkably dependent on the nature of the amine. Further, the stability of monofunctional adducts allows for competitive production of DNA–protein cross‐links and overall the results suggest that the trans‐platinum chemotype may offer significant potential for design of selective DNA–protein cross‐linking agents. A subset of proteins known to bind to DNA modified by trans‐platinum is that comprising zinc fingers – model studies show the potential for formation of heteronuclear thiolate‐bridged species as precedent for zinc displacement from the biomolecule.(© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2009)
📜 SIMILAR VOLUMES
Cisplatin (cis-DDP) and its cis-coordinated analogues, carboplatin and oxaliplatin, have been successfully used in the treatment of testicular and other solid tumors, but applications are restricted by side effects and intrinsic and acquired resistances. [1][2][3] The discovery of trans-coordinated
Cis-diamminedichloroplatinum (11) (cisplatin) is one of the most widely used anticancer drugs today. However, platinum compounds possessing the 1,2-diaminocyclohexane (DACH) carrier ligand offer advantages over cisplatin with regard to bioavailability, activity and decreased renal toxicity. diaminoc